300831-21-4

Basic information

• Product Name: 8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)-
• Synonyms: 8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)-;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]non-8-enoic acid;(S)-N-Boc-2-(6'-heptenyl)glycine;(2S)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]-8-nonenoic acid;non-8-enoic acid;(2S)-2-{[(tert-butoxy)carbonyl]amino}non-8-enoic acid
• CAS NO: 300831-21-4
• Molecular Formula: C₁₄H₂₅NO₄
• Molecular Weight: 271.35
• Mol File: 300831-21-4.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 422.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.035±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 4.01±0.21(Predicted)
• CAS DataBase Reference: 8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)-(300831-21-4)
• EPA Substance Registry System: 8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)-(300831-21-4)

Safety Data

• Hazardous Substances Data: 300831-21-4(Hazardous Substances Data)

Usage

General Description

The chemical "8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)-" is a compound that contains a 2-[(1,1-dimethylethoxy)carbonyl]amino group attached to a nonenoic acid chain. It exists in a specific stereochemical form known as (2S)-, indicating the orientation of the substituent groups around the chiral center. 8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (2S)- may have various industrial and pharmaceutical applications, potentially serving as a building block for the synthesis of other chemical compounds. Its precise properties and uses would depend on its specific application and context within the chemical industry.

Upstream product

• 300831-24-7 [(S)-1-((S)-4-Benzyl-2-oxo-oxazolidine-3-carbonyl)-oct-7-enyl]-carbamic acid tert-butyl ester 
• 915314-56-6 (R)-1-chloronon-8-en-2-ol 
• 300831-20-3 ethyl (S)-2-acetamido-8-nonenoate 
• 1058705-94-4 N-tert-butoxycarbonyl-2-amino-8-nonenoic acid dicyclohexylamine salt 
• 924307-76-6 (S)-2-amino-8-nonenoic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1039171-10-2 C₁₈H₃₁NO₅ 
• 1009637-39-1 2-tert-butoxycarbonylamino-8-nonenoic acid ethyl ester 
• 881683-81-4 ethyl (S)-((tert-butoxycarbonyl)amino)non-8-enoate 
• 756894-33-4 ethyl (Z)-2-acetamido-2,8-nonadienoate 
• 85866-02-0 7-octene-1,2-diol 
• 17206-61-0 hept-6-enal 
• 2695-48-9 8-Bromo-1-octene 
• 31642-67-8 non-8-enoic acid 

Downstream Products

• 1053233-06-9 (S)-2-tert-butoxycarbonylamino-8-nonenoic acid benzyl ester 
• 1219632-49-1 (2S,4R)-methyl 4-(allylthio)-4-(biphenyl-4-yl)-1-((S)-2-(tert-butoxycarbonylamino)non-8-enoyl)pyrrolidine-2-carboxylate 
• 1216941-64-8 (2S,6S,13aS,14aR,16aS,Z)-ethyl 2-(4-bromophenylsulfonyloxy)-6-(tert-butoxycarbonylamino)-5,16-dioxo-1,2,3,5, 6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydronaphthylcyclopropanoyl[e]pyrrolo[1,2-a][1,4] diazacyclopentadecyne-14a-carboxylate 
• 1352302-76-1 (3R,5S)-1-((S)-2-(tert-butoxycarbonylamino)non-8-enoyl)-5-((1R,2S)-1-(ethoxycarbonyl)-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl 4-nitrobenzoate 
• 790305-05-4 tert-butyl (2R,6S,13aS,14aR,16aS,Z)-14a-(cyclopropylsulfonylcarbamoyl)-2-hydroxy-5,16-dioxo-1,2,3,5,6,7,8, 9,10,11,13a,14,14a,15,16,16a-hexadecahydronaphthylcyclopropanoyl[e]pyrrolo[1,2-a][1,4]diazacyclopenta decyne-6-yl-carbamate 
• 552335-44-1 (1R,2S)-ethyl 1-((2S,4R)-1-((S)-2-(((tert-butoxy)carbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate 
• 1058705-94-4 N-tert-butoxycarbonyl-2-amino-8-nonenoic acid dicyclohexylamine salt 
• 1029259-59-3 C₃₈H₄₈N₄O₈S 
• 1029259-57-1 C₃₂H₄₄N₄O₈S 
• 1219015-43-6 C₃₆H₅₄N₄O₆ 
• 1219015-39-0 C₄₅H₇₂N₄O₉ 
• 1219015-42-5 C₃₅H₅₂N₄O₆ 

Relevant articles and documents

Synthetic method of optical activity N-tert-butoxycarbonyl-2-amino-8-nonenoic dicyclohexylamine salt

The invention provides a method for preparing optical activity N-tert-butoxycarbonyl-2-amino-8-nonenoic dicyclohexylamine salt, wherein X is halogen. The method realizes configuration inversion through a Mitsunobu reaction, and can obtain an optical purit

HEPATITIS C INHIBITOR COMPOUNDS

Compounds of the invention, which are macrocyclic peptide analogs containing an acylsulfonamide moiety, maintain good activity against NS3 proteases containing clinically relevant resistance mutations for this class as represented by genotype 1 a R155K, genotype 1 b D168V and genotype 1 a D168V resistance mutations. The compounds of the invention are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.

MACROCYCLIC INHIBITORS OF HEPATITIS C PROTEASE

The invention provides compounds inhibitory to the Hepatitis C viral protease, compositions and combinations including the compounds, methods of treatment of conditions wherein inhibition of the Hepatitis C viral protease is medically indicated, and metho